Depletion of pituitary prolactin by cysteamine is due to loss of immunological activity.
The mechanism by which cysteamine reduces the PRL content of pituitary cells was studied in primary cultures of estradiol-induced pituitary tumors in Fischer 344 rats. The PRL content of these cells was effectively decreased by cysteamine, with an IC50 of 0.2 mM. Cells previously labeled with [3H]leucine were exposed to cysteamine (0.25 mM), and the intracellular content of [3H]PRL was measured by immunological or nonimmunological means, that is by immunoprecipitation and electrophoresis or by electrophoresis alone. The intracellular concentration of immunoreactive [3H]PRL was reduced by 53% by cysteamine, whereas [3H]PRL quantified by electrophoresis alone was not significantly affected. Our data indicate that cysteamine reduces the PRL content of pituitary tumor cells by causing the loss of its immunoreactivity.
D000818:Animals; D002478:Cells, Cultured; D003543:Cysteamine / Q000494:pharmacology*; D005260:Female; D007106:Immune Sera; D007118:Immunoassay; D010911:Pituitary Neoplasms / Q000378:metabolism*; D011388:Prolactin / Q000276:immunology / Q000378:metabolism*; D051381:Rats; D011916:Rats, Inbred F344
D007106:Immune Sera; D003543:Cysteamine; D011388:Prolactin